Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 25, Issue 20, Pages 9814-9825Publisher
WILEY
DOI: 10.1111/jcmm.16929
Keywords
epithelial-mesenchymal transition; insulin-like growth factor-1; invasion; oral cancer; oral submucous fibrosis
Categories
Funding
- Ministry of Science and Technology, Taiwan [MOST 103-2632-B-040-001, MOST 104-2632-B-040-001, MOST 105-2632-B-040-001]
Ask authors/readers for more resources
Oral submucous fibrosis (OSF) plays a role in promoting the microenvironment of oral cancer cells, leading to increased invasion and epithelial-mesenchymal transition. Insulin-like growth factor-1 (IGF-1) is elevated in OSF, associated with upregulated IGF-1R protein levels and IGFR gene expression, with high IGFR expression in oral cancer patients correlating with poorer survival rates.
Oral submucous fibrosis (OSF) involves a high risk of malignant transformation and has been implicated in oral cancer. Limited studies have been conducted on the role of OSF in relation to the invasive capabilities and epithelial-mesenchymal transition (EMT) in oral cancer. Herein, we investigated the effects of OSF on the microenvironment of human oral cancer cells. The results showed that the conditioned medium (CM) of fibrotic buccal mucosal fibroblasts (fBMFs) strongly induced the invasion of oral cancer cells and increased the activities of matrix metalloproteinase-2. OSF significantly induced the EMT in oral cancer cells and downregulated epithelial markers, such as E-cadherin, but significantly elevated vimentin, fibronectin, N-cadherin, RhoA, Rac-1 and FAK. Insulin-like growth factor-1 (IGF-1) was elevated in OSF. The protein levels of the IGF-1R were upregulated specifically in fBMF CM treatment for oral cancer cells, and the IGFR gene was confirmed by The Cancer Genome Atlas patient transcriptome data. The Kaplan-Meier curve analysis revealed that patients with oral squamous cell carcinoma and high IGFR expression levels had poorer 5-year survival than those with low IGFR expression (p = 0.004). The fBMF-stimulated EMT cell model may recapture some of the molecular changes during EMT progression in clinical patients with oral cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available